To evaluate the efficacy and safety of olopatadine 0.1 & #37; ophthalmic solution and bepotastine 1.5 & #37; ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital
CONCLUSIONS: In this study, based on the evaluation of therapeutic performance, bepotastine eye drops proved quicker relief of symptoms and signs compared to olopatadine eye drops but was not statistically significant which would prove beneficial for the patients.
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Vadlakonda Sruthi Resu Neha Reddy K Sowmini Nagur Sharone Grace Source Type: research
More News: Allergy & Immunology | Conjunctivitis | Drugs & Pharmacology | India Health | Laboratory Medicine | Opthalmology | Statistics | Study